2015
DOI: 10.1038/pr.2015.75
|View full text |Cite
|
Sign up to set email alerts
|

The challenges of research participation by children

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
4
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(4 citation statements)
references
References 11 publications
0
4
0
Order By: Relevance
“…Developing research in vulnerable populations, such as pediatrics, is a challenging task. This can be seen in the fact that 70–90% of the drugs prescribed for this population are used off-label, showing that the lack of data derived from research in children is not limited to the subject of pediatric regional anesthesia but extends to all areas of medicine [ 30 ].…”
Section: Discussionmentioning
confidence: 99%
“…Developing research in vulnerable populations, such as pediatrics, is a challenging task. This can be seen in the fact that 70–90% of the drugs prescribed for this population are used off-label, showing that the lack of data derived from research in children is not limited to the subject of pediatric regional anesthesia but extends to all areas of medicine [ 30 ].…”
Section: Discussionmentioning
confidence: 99%
“…Despite this increasing ability to comprehend research enrollment and participation, a recent review found that only nine of 52 studies on randomized clinical trial enrollment reported patient preferences alongside those of parents [20]. As multiple authors and agencies have asserted, “children should not be either burdened or excluded from participation in research” [18,20,21,22]. Legally, children under the age of 18 years cannot consent to treatment unless there are specific extenuating circumstances (i.e., the adolescent is a legally emancipated minor) [23]; however, children under the age of 18 should be asked to provide assent—especially for research procedures that do not offer direct benefits to the child [24].…”
Section: Children With Cancer: Illness Experiencesmentioning
confidence: 99%
“…Legally, children under the age of 18 years cannot consent to treatment unless there are specific extenuating circumstances (i.e., the adolescent is a legally emancipated minor) [23]; however, children under the age of 18 should be asked to provide assent—especially for research procedures that do not offer direct benefits to the child [24]. As these decisions are often made by weighing the potential risks and benefits of participation [21], and participation directly involves and impacts the child or adolescent, it is essential that providers and researchers utilize age-appropriate, context-specific, and child-centered techniques for recruitment, informed consent/assent, and data collection as discussed in more detail below [14].…”
Section: Children With Cancer: Illness Experiencesmentioning
confidence: 99%
“…Children are considered a vulnerable population, increasing the challenges of recruitment for clinical trials. 1 The main challenge is ethical, mostly due to a child's incapability to consent to be submitted to a clinical trial. Also, physiological development makes the child more susceptible and with a higher risk for long-term harm and changes.…”
mentioning
confidence: 99%